The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke

Ching Ping Chang, Wu Tein Huang, Bor Chih Cheng, Chuan Chih Hsu, Mao Tsun Lin

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The present study was performed to assess the prophylactic effect of baicalin, a flavonoid compound, in an animal model of heatstroke. Anesthetized rats, immediately before the start of heat stress, were divided into two major groups and given the following: vehicle solution (1 mL per kg body weight) or baicalin (10-40 mg per kg body weight) intravenously. They were exposed to ambient temperature of 43 °C to induce heatstroke. Another group of rats was exposed to room temperature (24 °C) and used as normothermic controls. Their physiologic and biochemical parameters were continuously monitored. When the vehicle-pretreated rats underwent heat stress, their survival time values were found to be 20-28 min. Pretreatment with intravenous doses of baicalin significantly improved survival during heatstroke (65-248 min). As compared to those of normothermic controls, all vehicle-pretreated heatstroke animals displayed higher levels of core temperature, intracranial pressure, and nitric oxide metabolite (NO2 -), glutamate, glycerol, lactate/pyruvate ratio, and dihydroxybenzoic acid (DHBA) in hypothalamus. In addition, both serum and hypothalamic levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) as well as plasma levels of creatinine, serum urea nitrogen, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and alkaline phosphatase were elevated after heatstroke onset. In contrast, all vehicle-pretreated heatstroke animals had lower levels of mean arterial pressure, cerebral perfusion pressure, cerebral blood flow, and brain PO2. Administration of baicalin before the start of heat exposure significantly reduced the hyperthermia, intracranial hypertension, and the increased levels of NO2 -, glutamate, glycerol, lactate/pyruvate ratio, and DHBA in the hypothalamus that occurred during heatstroke. The heatstroke-induced increased levels of IL-1β and TNF-α in both the serum and hypothalamus, and renal and hepatic dysfunction were suppressed by baicalin pretreatment. In contrast, both the serum and hypothalamic levels of IL-10 were significantly elevated by baicalin during heatstroke. We successfully demonstrated that baicalin can be used as a prophylactic agent for heatstroke. In particular, baicalin may protect against cerebrovascular dysfunction and brain inflammation in heatstroke.

Original languageEnglish
Pages (from-to)1024-1033
Number of pages10
JournalNeuropharmacology
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 2007
Externally publishedYes

Fingerprint

Heat Stroke
Encephalitis
Flavonoids
Cerebrovascular Circulation
Hypothalamus
Hot Temperature
Serum
Pyruvic Acid
Interleukin-1
Glycerol
Temperature
Glutamic Acid
Lactic Acid
baicalin
Tumor Necrosis Factor-alpha
Body Weight
Acids
Intracranial Hypertension
Intracranial Pressure
Aspartate Aminotransferases

Keywords

  • Cerebral blood flow
  • Cytokines
  • Heatstroke
  • Hypotension
  • Intracranial pressure

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke. / Chang, Ching Ping; Huang, Wu Tein; Cheng, Bor Chih; Hsu, Chuan Chih; Lin, Mao Tsun.

In: Neuropharmacology, Vol. 52, No. 3, 03.2007, p. 1024-1033.

Research output: Contribution to journalArticle

Chang, Ching Ping ; Huang, Wu Tein ; Cheng, Bor Chih ; Hsu, Chuan Chih ; Lin, Mao Tsun. / The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke. In: Neuropharmacology. 2007 ; Vol. 52, No. 3. pp. 1024-1033.
@article{d1c8240dd1344132bd289ac367796ec4,
title = "The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke",
abstract = "The present study was performed to assess the prophylactic effect of baicalin, a flavonoid compound, in an animal model of heatstroke. Anesthetized rats, immediately before the start of heat stress, were divided into two major groups and given the following: vehicle solution (1 mL per kg body weight) or baicalin (10-40 mg per kg body weight) intravenously. They were exposed to ambient temperature of 43 °C to induce heatstroke. Another group of rats was exposed to room temperature (24 °C) and used as normothermic controls. Their physiologic and biochemical parameters were continuously monitored. When the vehicle-pretreated rats underwent heat stress, their survival time values were found to be 20-28 min. Pretreatment with intravenous doses of baicalin significantly improved survival during heatstroke (65-248 min). As compared to those of normothermic controls, all vehicle-pretreated heatstroke animals displayed higher levels of core temperature, intracranial pressure, and nitric oxide metabolite (NO2 -), glutamate, glycerol, lactate/pyruvate ratio, and dihydroxybenzoic acid (DHBA) in hypothalamus. In addition, both serum and hypothalamic levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) as well as plasma levels of creatinine, serum urea nitrogen, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and alkaline phosphatase were elevated after heatstroke onset. In contrast, all vehicle-pretreated heatstroke animals had lower levels of mean arterial pressure, cerebral perfusion pressure, cerebral blood flow, and brain PO2. Administration of baicalin before the start of heat exposure significantly reduced the hyperthermia, intracranial hypertension, and the increased levels of NO2 -, glutamate, glycerol, lactate/pyruvate ratio, and DHBA in the hypothalamus that occurred during heatstroke. The heatstroke-induced increased levels of IL-1β and TNF-α in both the serum and hypothalamus, and renal and hepatic dysfunction were suppressed by baicalin pretreatment. In contrast, both the serum and hypothalamic levels of IL-10 were significantly elevated by baicalin during heatstroke. We successfully demonstrated that baicalin can be used as a prophylactic agent for heatstroke. In particular, baicalin may protect against cerebrovascular dysfunction and brain inflammation in heatstroke.",
keywords = "Cerebral blood flow, Cytokines, Heatstroke, Hypotension, Intracranial pressure",
author = "Chang, {Ching Ping} and Huang, {Wu Tein} and Cheng, {Bor Chih} and Hsu, {Chuan Chih} and Lin, {Mao Tsun}",
year = "2007",
month = "3",
doi = "10.1016/j.neuropharm.2006.10.018",
language = "English",
volume = "52",
pages = "1024--1033",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke

AU - Chang, Ching Ping

AU - Huang, Wu Tein

AU - Cheng, Bor Chih

AU - Hsu, Chuan Chih

AU - Lin, Mao Tsun

PY - 2007/3

Y1 - 2007/3

N2 - The present study was performed to assess the prophylactic effect of baicalin, a flavonoid compound, in an animal model of heatstroke. Anesthetized rats, immediately before the start of heat stress, were divided into two major groups and given the following: vehicle solution (1 mL per kg body weight) or baicalin (10-40 mg per kg body weight) intravenously. They were exposed to ambient temperature of 43 °C to induce heatstroke. Another group of rats was exposed to room temperature (24 °C) and used as normothermic controls. Their physiologic and biochemical parameters were continuously monitored. When the vehicle-pretreated rats underwent heat stress, their survival time values were found to be 20-28 min. Pretreatment with intravenous doses of baicalin significantly improved survival during heatstroke (65-248 min). As compared to those of normothermic controls, all vehicle-pretreated heatstroke animals displayed higher levels of core temperature, intracranial pressure, and nitric oxide metabolite (NO2 -), glutamate, glycerol, lactate/pyruvate ratio, and dihydroxybenzoic acid (DHBA) in hypothalamus. In addition, both serum and hypothalamic levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) as well as plasma levels of creatinine, serum urea nitrogen, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and alkaline phosphatase were elevated after heatstroke onset. In contrast, all vehicle-pretreated heatstroke animals had lower levels of mean arterial pressure, cerebral perfusion pressure, cerebral blood flow, and brain PO2. Administration of baicalin before the start of heat exposure significantly reduced the hyperthermia, intracranial hypertension, and the increased levels of NO2 -, glutamate, glycerol, lactate/pyruvate ratio, and DHBA in the hypothalamus that occurred during heatstroke. The heatstroke-induced increased levels of IL-1β and TNF-α in both the serum and hypothalamus, and renal and hepatic dysfunction were suppressed by baicalin pretreatment. In contrast, both the serum and hypothalamic levels of IL-10 were significantly elevated by baicalin during heatstroke. We successfully demonstrated that baicalin can be used as a prophylactic agent for heatstroke. In particular, baicalin may protect against cerebrovascular dysfunction and brain inflammation in heatstroke.

AB - The present study was performed to assess the prophylactic effect of baicalin, a flavonoid compound, in an animal model of heatstroke. Anesthetized rats, immediately before the start of heat stress, were divided into two major groups and given the following: vehicle solution (1 mL per kg body weight) or baicalin (10-40 mg per kg body weight) intravenously. They were exposed to ambient temperature of 43 °C to induce heatstroke. Another group of rats was exposed to room temperature (24 °C) and used as normothermic controls. Their physiologic and biochemical parameters were continuously monitored. When the vehicle-pretreated rats underwent heat stress, their survival time values were found to be 20-28 min. Pretreatment with intravenous doses of baicalin significantly improved survival during heatstroke (65-248 min). As compared to those of normothermic controls, all vehicle-pretreated heatstroke animals displayed higher levels of core temperature, intracranial pressure, and nitric oxide metabolite (NO2 -), glutamate, glycerol, lactate/pyruvate ratio, and dihydroxybenzoic acid (DHBA) in hypothalamus. In addition, both serum and hypothalamic levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) as well as plasma levels of creatinine, serum urea nitrogen, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and alkaline phosphatase were elevated after heatstroke onset. In contrast, all vehicle-pretreated heatstroke animals had lower levels of mean arterial pressure, cerebral perfusion pressure, cerebral blood flow, and brain PO2. Administration of baicalin before the start of heat exposure significantly reduced the hyperthermia, intracranial hypertension, and the increased levels of NO2 -, glutamate, glycerol, lactate/pyruvate ratio, and DHBA in the hypothalamus that occurred during heatstroke. The heatstroke-induced increased levels of IL-1β and TNF-α in both the serum and hypothalamus, and renal and hepatic dysfunction were suppressed by baicalin pretreatment. In contrast, both the serum and hypothalamic levels of IL-10 were significantly elevated by baicalin during heatstroke. We successfully demonstrated that baicalin can be used as a prophylactic agent for heatstroke. In particular, baicalin may protect against cerebrovascular dysfunction and brain inflammation in heatstroke.

KW - Cerebral blood flow

KW - Cytokines

KW - Heatstroke

KW - Hypotension

KW - Intracranial pressure

UR - http://www.scopus.com/inward/record.url?scp=33846938772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846938772&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2006.10.018

DO - 10.1016/j.neuropharm.2006.10.018

M3 - Article

C2 - 17204294

AN - SCOPUS:33846938772

VL - 52

SP - 1024

EP - 1033

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -